Ledger.Open graph →
SEC Form D · filed October 20, 2017

Prelude Therapeutics Inc

Offering
$12.0M
Sold
$12.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEWARK, DE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Juan Luengo · Newark, DEExecKrishna Vaddi · Chadds Ford, PAExec · DirectorPaul Friedman · New York, NYDirectorKelvin Neu · San Francisco, CADirectorDavid Bonita · Montreal, Quebec, CanadaDirectorJuan Luengo · Newark, DEExecKrishna Vaddi · Chadds Ford, PAExec · DirectorPaul Friedman · San Francisco, CADirectorKelvin Neu · Newark, DEDirectorDavid Bonita · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗